Peer Review reports
From: Combination of pemetrexed with bevacizumab for non-small-cell lung cancer: a meta-analysis study
| Original Submission | ||
|---|---|---|
| 8 Aug 2023 | Submitted | Original manuscript |
| 11 Sep 2023 | Reviewed | Reviewer Report |
| 30 Sep 2023 | Reviewed | Reviewer Report |
| 16 Oct 2023 | Author responded | Author comments - Wei Fang |
| 22 Oct 2023 | Author responded | Author comments - Wei Fang |
| Resubmission - Version 2 | ||
| 16 Oct 2023 | Submitted | Manuscript version 2 |
| 27 Oct 2023 | Author responded | Author comments - Wei Fang |
| Resubmission - Version 3 | ||
| 27 Oct 2023 | Submitted | Manuscript version 3 |
| 4 Nov 2023 | Author responded | Author comments - Wei Fang |
| Resubmission - Version 4 | ||
| 4 Nov 2023 | Submitted | Manuscript version 4 |
| Publishing | ||
| 30 Jan 2024 | Editorially accepted | |
| 2 Aug 2024 | Article published | 10.1186/s13019-024-02975-6 |
You can find further information about peer review here.